Treatment of BRAF ( B-Rapidly Accelerated Fibrosarcoma) Mutated Papillary Craniopharyngioma
Clinical trial NCT05525273 · RECRUITING
Trial details
- NCT number
- NCT05525273
- Sponsor
- Eva Marie Erfurth, MD, PhD
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-01
- Primary completion
- 2027-09-10
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.